Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Liu, Ningning; Li, Xiaofen; Huang, Hongbiao; Zhao, Chong; Zhao, Chong; Liao, Siyan; Yang, Changshan; Liu, Shouting; Song, Wenbin; Lan, Xiaoying; Lan, Xiaoying; Chen, Xin; Yi, Songgang; Xu, Li; Jiang, Lili; Zhao, Canguo; Zhao, Canguo; Dong, Xiaoxian; Zhou, Ping; Li, Shujue; Wang, Shunqing; Shi, Xianping; Q. Dou, Ping; Wang, Xuejun; Liu, Jinbao

doi:10.18632/oncotarget.2113

Public

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Published in Oncotarget • Jun 18, 2014

Authors:

Ningning Liu

Xiaofen Li

Hongbiao Huang

Abstract

// Ningning Liu 1,2,* , Xiaofen Li 1,* , Hongbiao Huang 1,* , Chong Zhao 1,* , Siyan Liao 1,* , Changshan Yang 1,* , Shouting Liu 1,* , Wenbin Song 1 , Xiaoyu Lu 1 , Xiaoying Lan 1 , Xin Chen 1 , Songgang Yi 1 , Li Xu 1,3 , Lili Jiang 1 , Canguo Zhao 1 , Xiaoxian Dong 1 , Ping Zhou 1 , Shujue Li 1,4...

Subject

Auranofin

Bortezomib

Proteasome

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!